Lonza Bags Manufacturing Contract Using Microreactor Technology

Lonza says it has won a manufacturing contract with a big pharma company, and the manufacture of the product will be based on Lonza’s proprietary microreactor technology (MRT), enabling scale-up, clinical trials, and large-scale commercial quantities. Further details of the contract were not disclosed. MRT utilizes continuous flow processes based on plug flow reactors and it requires minimal reagent volumes while offering rapid dynamic responses and robustness, Lonza says. MRT offers new chemical routes, reduced solvent usage, higher yields than...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers